Angiochem
Business Services · Canada · 11-50 Employees
View Company Info for Free
Overview
Headquarters
4150 St Catherine St West Ste 490, Westm...Phone Number
(514) 788-7800Website
www.angiochem.comRevenue
$5.6 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Angiochem
Angiochem is a clinical-stage biotechnology company discovering and developing new breakthrough peptide drug conjugates to treat neurological diseases. AngioChem was founded in 2003 and based in Quebec, Canada.Explore more
Angiochem Org Chart
CN
Research Associate
VP
TSA-assistante De Recherche
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Angiochem your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Angiochem has recently received funding, and reach out quickly before it becomes old news!
Click to see if Angiochem had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Angiochem
Earning: See what the market has to say on Angiochem recently announced quarterly report
Check out if Angiochem is spiking on competitors!
Funding: Get notified immidiatlly once Angiochem has new funding data
Angiochem, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Angiochem launches new products
Recommended Actions
Find VP level buyers at Angiochem
Find 2 more new buyers
Compare Similar Companies to Angiochem
Compare insights from companies similar to Angiochem, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Angiochem is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Angiochem is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Angiochem.
Angiochem financials insights
Gather financial insights about Angiochem, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2018
Series C
$7.5M
Angiochem Tech Stack
A closer look at the technologies used by Angiochem
Angiochem News & Media
Angiochem Receives Loan from Quebec Government to Perform Phase III Trial
MONTREAL, June 04, 2019 (GLOBE NEWSWIRE) -- Angiochem Inc. (“Angiochem”) announced today that it has been granted a $4 million loan from the Quebec Government through its BioMed Propulsion program. The funds will help Angiochem conduct its Phase III clinical trial for ANG1005.Angiochem Announces Special Protocol Assessment (SPA) with US Food and Drug Administration (FDA)
MONTREAL, Aug. 06, 2018 (GLOBE NEWSWIRE) -- Angiochem Inc. (“Angiochem”) announced today that it has reached an agreement with the U.S. Food and Drug Administration (FDA) regarding a Special Protocol Assessment (SPA) on the design, endpoints and statistical analysis plan for a Phase 3 clinical trial for ANG1005.
Read more news
Top Business Services Companies
Top companies in New Zealand by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding Angiochem
Sign Up For FreeTo access detailed company insights
Angiochem is a clinical-stage biotechnology company discovering and developing new breakthrough peptide drug conjugates to treat neurological diseases. AngioChem was founded in 2003 and based in Quebec, Canada.... Read More
